74
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Clinical Profile of HLA-B27-Associated Uveitis in an Egyptian Cohort

ORCID Icon & ORCID Icon
Pages 3821-3828 | Published online: 10 Nov 2020

References

  • Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. 1996;80:844–848. doi:10.1136/bjo.80.9.844
  • Majumdar AK, Kumar A, Roy R, et al. Clinical profile of HLA-B27-associated uveitis patients in a tertiary care eye hospital in eastern India. Ocul Immunol Inflamm. 2018:1–4. doi:10.1080/09273948.2018.1484491
  • Brewerton D, Caftrey M, Nicholls A, Walters D, James DCO. Acute anterior uveitis and HLA B27. Lancet. 1973;2(7836):994–996. doi:10.1016/S0140-6736(73)91090-8
  • McCannel CA, Holland GN, Helm CJ, et al. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol. 1996;121(1):35–46. doi:10.1016/S0002-9394(14)70532-X
  • Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol. 2005;50(4):364–388. doi:10.1016/j.survophthal.2005.04.003
  • Accorinti M, Iannetti L, Liverani M, et al. Clinical features and prognosis of HLA B27-associated acute anterior uveitis in an Italian patient population. Ocul Immunol Inflamm. 2010;18(2):91–96. doi:10.3109/09273941003597268
  • Wakefield D, Chang JH, Amjadi S, et al. What is new HLA-B27 acute anterior uveitis? Ocul Immunol Inflamm. 2011;19(2):139–144. doi:10.3109/09273948.2010.542269
  • Inanc M, Şimşek M, Ozdal MPC. Etiological and clinical characteristics of HLA-B27-associated uveitis in a tertiary referral center. Turk J Ophthalmol. 2019;49(1):10–14. doi:10.4274/tjo.galenos.2018.53896
  • Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–516.
  • Lange C, Feltgen N, Junker B, et al. Resolving the clinical acuity categories “hand motion” and “counting fingers” using the Freiburg Visual Acuity Test (FrACT). Graefes Arch Clin Exp Ophthalmol. 2009;247(1):137–142. doi:10.1007/s00417-008-0926-0
  • Kwon YH, Kim CS, Zimmerman MB, et al. Rate of visual field loss and long-term visual outcome in primary open-angle glaucoma. Am J Ophthalmol. 2001;132(1):47–56. doi:10.1016/S0002-9394(01)00912-6
  • Brewerton DA, Hart FD, Nicholls A, et al. Ankylosing spondylitis and HLA B27. Lancet. 1973;301(7809):904–907. doi:10.1016/S0140-6736(73)91360-3
  • Abd El Latif E, Ammar H. Uveitis referral pattern in upper and lower Egypt. Ocul Immunol Inflamm. 2019;27(6):875–882. doi:10.1080/09273948.2017.1410183
  • Chang JH-M, Wakefield D. Uveitis: a global perspective. Ocul Immunol Inflamm. 2002;10:263–279. doi:10.1076/ocii.10.4.263.15592
  • Rodriguez A, Calonge M, Pedroza-Seres M, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol. 1996;114(5):593–599. doi:10.1001/archopht.1996.01100130585016
  • Pivetti-Pezzi P, Accorinti M, La Cava M, et al. Endogenous uveitis: an analysis of 1417 cases. Ophthalmologica. 1996;210(4):234–238. doi:10.1159/000310715
  • Ziade NR. HLA B27 antigen in Middle Eastern and Arab countries: systematic review of the strength of association with axial spondyloarthritis and methodological gaps. BMC Musculoskelet Disord. 2017;18(1):280. doi:10.1186/s12891-017-1639-5
  • Reveille JD, Hirsch R, Dillon CF, et al. The prevalence of HLA-B27 in the US: data from the US National Health and Nutrition Examination Survey, 2009. Arthritis Rheum. 2012;64(5):1407–1411. doi:10.1002/art.33503
  • Abdulaal M, Antonios R, Barikian A, et al. Etiology and clinical features of ocular inflammatory diseases in a tertiary center in Lebanon. Ocul Immunol Inflamm. 2014;9:1–7.
  • Al Dhahri H, Al Rubaie K, Hemachandaran S, et al. Patterns of uveitis in a university-based tertiary referral center in Riyadh, Saudi Arabia. Ocul Immunol Inflamm. 2014;24:1–9.
  • Nizamuddin SH, Bawazeer AM. Causes of uveitis in a tertiary center in Western Saudi Arabia. Saudi Med J. 2013;34:379–387.
  • Bawazeer AM, Joharjy HI. The association of human leukocyte antigen B27 with anterior uveitis in patients from the western region of Saudi Arabia: a retrospective study. Clin Ophthalmol. 2013;7:2107–2111. doi:10.2147/OPTH.S53518
  • Paivonsalo-Hietanen T, Vaahtoranta-Lehtonen H, Tuominen J, et al. Uveitis survey at the University Eye Clinic Turku. Acta Ophthalmol. 1994;72:505–512. doi:10.1111/j.1755-3768.1994.tb02805.x
  • Thean LH, Thompson J, Rosenthal AR. A uveitis register at the Leicester royal infirmary. Ophthal Epidemiol. 1996;3:151–158. doi:10.3109/09286589609080121
  • Kotake S, Furudate N, Sasamoto Y, et al. Characteristics of endogenous uveitis n Hokkaido, Japan. Graefes Arch Clin Exp Ophthalmol. 1997;235(1):5–9. doi:10.1007/BF01007830
  • Rothova A, Van Veenedaal WG, Linssen A, et al. Clinical features of acute anterior uveitis. Am J Ophthalmol. 1987;103(2):137–145. doi:10.1016/S0002-9394(14)74218-7
  • Pathanapitoon K, Suksomboon S, Kunavisarut P, et al. HLA-B27-associated acute anterior uveitis in the university referral centre in North Thailand: clinical presentation and visual prognosis. Br J Ophthalmol. 2006;90(12):1448–1450. doi:10.1136/bjo.2006.099788
  • Kazokoglu H, Onal S, Tugal-Tutkun I, et al. Demographic and clinical features of uveitis in tertiary centers in Turkey. Ophthalmic Epidemiol. 2008;15(5):285–293. doi:10.1080/09286580802262821
  • Rodriguez A, Ya A, Pedroza-Seres M, et al. Posterior segment ocular manifestations in patients with HLA-B27-associated uveitis. Ophthalmology. 1994;101:1267–1274. doi:10.1016/S0161-6420(94)31179-1
  • Sanghvi C, Mercieca K, Jones NP. Very severe HLA-B27-associated panuveitis mimicking endophthalmitis: a case series. Ocul Immunol Inflamm. 2010;18(2):139–141. doi:10.3109/09273940903560236
  • Braakenburg AM, Rothova A. The clinical characteristics of retinal vasculitis in HLA-B27-positive patients. Ocul Immunol Inflamm. 2014;22(3):197–202. doi:10.3109/09273948.2013.835429
  • Pathanapitoon K, Dodds EM, Jr ET C, et al. Clinical spectrum of HLA-B27-associated ocular inflammation. Ocul Immunol Inflamm. 2017;25(4):569–576. doi:10.1080/09273948.2016.1185527
  • Valls Pascual E, Fontanilla Ortega P, Vicens Bernabeu E, et al. Clinical characteristics, treatment and ocular complications of HLA-B27-related anterior uveitis and HLA-B27-non related anterior uveitis. Reumatol Clin. 2016;12(5):244–247. doi:10.1016/j.reuma.2015.11.008
  • Power WJ, Rodriguez A, Pedroza-Seres M, et al. Outcomes in anterior uveitis associated with the HLA-B27 haplotype. Ophthalmology. 1998;105(9):1646–1651. doi:10.1016/S0161-6420(98)99033-9
  • Tay-Kearney M, Schwam BL, Lowder C, et al. Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol. 1996;121(1):47–56. doi:10.1016/S0002-9394(14)70533-1
  • Wakefield D, Easter J, Penny R. Clinical features of HLA-B27 anterior uveitis. Aust J Ophthalmol. 1984;12(3):191–196. doi:10.1111/j.1442-9071.1984.tb01155.x
  • Duker JS, Brown GC, Brooks L. Retinal vasculitis in Crohn’s disease. Am J Ophthalmol. 1987;103:664–668. doi:10.1016/S0002-9394(14)74326-0
  • Ruby AJ, Jampol LM. Crohn’s disease and retinal vascular disease. Am J Ophthalmol. 1990;110:349–353. doi:10.1016/S0002-9394(14)77013-8
  • Park SC, Ham D-I. Clinical features and prognosis of HLA-B27 positive and negative anterior uveitis in a Korean population. J Korean Med Sci. 2009;24(4):722–728. doi:10.3346/jkms.2009.24.4.722
  • Roe R, Branco BC, Cunningham ET. Hypotony maculopathy in a patient with HLA-B27-associated uveitis. Ocul Immunol Inflamm. 2008;16(3):107–108. doi:10.1080/09273940802023794
  • Van Der Veer EG, Keunen JE, Rothova RA. Severe HLA B27-associated uveitis complicated by hypotony, serous retinal detachment, and ciliochoroidal effusion. Ocul Immunol Inflamm. 2014;22(1):23–26. doi:10.3109/09273948.2013.828081
  • D’Ambrosio EM, La Cava M, Tortorella P, et al. Clinical features and complications of the HLA-B27-associated acute anterior uveitis: a metanalysis. Semin Ophthalmol. 2016. doi:10.3109/08820538.2016.1170158